Unicon Optical Co., Ltd. (4150.TWO)

TWD 13.95

(-2.45%)

EBITDA Summary of Unicon Optical Co., Ltd.

  • Unicon Optical Co., Ltd.'s latest annual EBITDA in 2023 was 377.24 Million TWD , up 377.34% from previous year.
  • Unicon Optical Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was -832.5 Thousand TWD , down 0.0% from previous quarter.
  • Unicon Optical Co., Ltd. reported an annual EBITDA of -103.2 Million TWD in 2022, up 25.44% from previous year.
  • Unicon Optical Co., Ltd. reported an annual EBITDA of -131.59 Million TWD in 2021, up 44.35% from previous year.
  • Unicon Optical Co., Ltd. reported a quarterly EBITDA of -832.5 Thousand TWD for 2024 Q1, down -106.82% from previous quarter.
  • Unicon Optical Co., Ltd. reported a quarterly EBITDA of 12.21 Million TWD for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Unicon Optical Co., Ltd. (2023 - 2019)

Historical Annual EBITDA of Unicon Optical Co., Ltd. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 377.24 Million TWD 377.34%
2022 -103.2 Million TWD 25.44%
2021 -131.59 Million TWD 44.35%
2020 -316.39 Million TWD -584.21%
2019 -15.49 Million TWD 0.0%

Peer EBITDA Comparison of Unicon Optical Co., Ltd.

Name EBITDA EBITDA Difference
St.Shine Optical Co.,Ltd. 1.01 Billion TWD 62.687%
Bioteque Corporation 736.13 Million TWD 48.753%
Chi Sheng Pharma & Biotech Co., Ltd 117.55 Million TWD -220.921%
Sunder Biomedical Tech. Co., Ltd. 76.61 Million TWD -392.409%
BenQ Medical Technology Corporation 532.15 Million TWD 29.109%
Pacific Hospital Supply Co., Ltd 673.8 Million TWD 44.012%
Formosa Optical Technology Co.,Ltd. 1.04 Billion TWD 63.916%
Medeon Biodesign, Inc. -1.14 Billion TWD 133.036%
Concord Medical Co., Ltd. 137.47 Million TWD -174.415%
Crystalvue Medical Corporation 149.73 Million TWD -151.951%
Perfect Medical Industry Co., Ltd. 115.48 Million TWD -226.679%
ICARES Medicus, Inc. 165.54 Million TWD -127.889%
Lagis Enterprise Co., Ltd. 112.36 Million TWD -235.738%
Amed Co., Ltd. 157.32 Million TWD -139.788%